China SXT Pharmaceuticals (SXTC) Revenue (2017 - 2025)
China SXT Pharmaceuticals (SXTC) revenue from Mar 31, 2017 to Mar 31, 2025. The TTM China SXT Pharmaceuticals (SXTC) revenue is $1.74M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
China SXT Pharmaceuticals (SXTC) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -9.84% |
| 3 Years | -12.53% |
| 5 Years | -19.54% |
| All Time | -12.09% |
Annual Revenue change of China SXT Pharmaceuticals (SXTC)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $1.74M | -9.84% |
| 2024 | $1.93M | -2.03% |
| 2023 | $1.97M | -24.23% |
| 2022 | $2.60M | -45.61% |
| 2021 | $4.78M | -7.36% |
| 2020 | $5.16M | -26.39% |
| 2019 | $7.01M | -0.14% |
| 2018 | $7.02M | +43.85% |
| 2017 | $4.88M | N/A |
Comparison China SXT Pharmaceuticals (SXTC) five years revenue CAGR with competitors
China SXT Pharmaceuticals (SXTC) five years revenue CAGR is -18.28%.